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Abstract
In tauopathies, such as Alzheimer’s disease with or without concomitant amy-
loid b plaques, cerebral arteries display pathological remodeling, leading to
reduced brain tissue oxygenation and cognitive impairment. The precise
mechanisms that underlie this vascular dysfunction remain unclear. Kv7 volt-
age-dependent K+ channels contribute to the development of myogenic tone
in rat cerebral arteries. Thus, we hypothesized that Kv7 channel function
would be impaired in the cerebral arteries of a tauopathy mouse model
(rTg4510), which might underlie cerebral hypoperfusion associated with the
development of neurofibrillary tangles in tauopathies. To test our hypothesis
we performed wire myography and quantitative PCR on cerebral arteries,
mesenteric arteries and the inferior frontotemporal region of the brain sur-
rounding the middle cerebral artery from tau transgenic mice (rTg4510) and
aged-matched controls. We also performed whole-cell patch clamp experi-
ments on HEK293 cells stably expressing Kv7.4. Here, we show that Kv7 chan-
nels are functionally impaired in the cerebral arteries of rTg4510 mice, but
not in mesenteric arteries from the same mice. The quantitative PCR analysis
of the cerebral arteries found no change in the expression of the genes encod-
ing the Kv7 channel a-subunits, however, we found reduced expression of the
ancillary subunit, KCNE5 (also termed KCNE1L), in the cerebral arteries of
rTg4510 mice. In the brain, rTg4510 mice showed reduced expression of
Kv7.3, Kv7.5, and Kv2.1. Co-expression of KCNE5 with Kv7.4 in HEK293 cells
produced larger currents at voltages >0 mV and increased the deactivation
time for the Kv7.4 channel. Thus, our results demonstrate that Kv7 channel
function is attenuated in the cerebral arteries of Tg4510 mice, which may
result from decreased KCNE5 expression. Reduced Kv7 channel function
might contribute to cerebral hypoperfusion in tauopathies, such as Alzhei-
mer’s disease.
Introduction
The prevalence of neurodegenerative diseases is increasing
worldwide with dementias being responsible for the great-
est burden of the disease (Prince et al. 2013). One group
of neurodegenerative diseases, which result from the grad-
ual and progressive loss of neural cells, are characterized
by the formation of neurofibrillary tangles (NFTs) arising
from dysfunction and aggregation of the microtubule-
associated protein tau. These conditions are known as
tauopathies and include Alzheimer’s disease (AD), Pick’s
disease and frontotemporal dementia with parkinsonism
linked to chromosome 17 (FTDP-17). AD remains the
most common cause of dementia and NFTs have been
detected in the early neurodegeneration stages before fully
developed AD, regardless of concomitant amyloid b pla-
ques (Braak and Braak 1991; Duyckaerts et al. 2015). It is
now known that AD is characterized by cerebrovascular
remodeling, which occurs before the onset of neurodegen-
eration, increasing vascular resistance in the cerebral cir-
culation and decreasing cerebral blood flow (Zhao et al.
2014; Bradley et al. 2002; Merlini et al. 2016; Qiu et al.
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2016). In particular, cerebral arteries in tauopathies dis-
play early pathological vessel wall remodeling, leading to
reduced brain tissue oxygenation and cognitive impair-
ment (Perry et al. 1998; Vidal et al. 2000; Stopa et al.
2008; Merlini et al. 2016). The precise mechanisms that
underlie this vascular dysfunction remain unclear.
Kv7 channels are voltage-dependent K+ channels,
encoded for by the KCNQ genes, which are important
determinants of the resting membrane potential in vascu-
lar and non-vascular smooth muscle cells (Jepps et al.
2013; Greenwood and Tribe 2014; Stott et al. 2014;
Fosmo and Skraastad 2017; Byron and Brueggemann
2018), the action potential propagation in neurons (Wang
and Li 2016), and the major repolarization current in the
heart (IKs) (Barhanin et al. 1996; Sanguinetti et al. 1996).
In smooth muscle cells of rat cerebral arteries, Kv7.4 and
Kv7.5 channels regulate myogenic tone, with inhibition of
these channels resulting in increased cerebral artery resis-
tance at physiological pressures (Zhong et al. 2010a; Mani
et al. 2011, 2013).
Given the importance of Kv7 channels in regulating
cerebral artery tone and the decreased cerebral blood flow
associated with tauopathies related to AD, we hypothe-
sized that Kv7 channel function would be impaired in the
cerebral arteries of a tauopathy mouse model (rTg4510),
which might underlie cerebral hypoperfusion associated
with the development of NFTs and AD. The rTg4510
mouse model of tauopathy carries human tau containing
the P301L mutation (4R0N) linked to familial frontotem-
poral dementia (described in Ramsden et al. (2005)) and
displays age-dependent learning and memory impair-
ments, hyperactivity and neurodegeneration correlating
with tau pathology (Santacruz et al. 2005; Ramsden et al.
2005; Cook et al. 2014; Jul et al. 2016; Helboe et al.
2017). Thus, the aim of this study was to investigate the
function and expression of Kv7 channels (and associated
proteins) in cerebral arteries of the rTg4510 mouse model
of tau hyperphosphorylation and age-matched control
mice.
Material and Methods
Animals
Male wild-type (WT) and the rTg(tauP301L)4510 mice
(11 months old) were used in this study. The rTg4510
strain is created by crossing two transgenic parental
strains. One contains P301L-hTau downstream of an
inducible tetracycline-operonresponder (TRE) promoter.
The second contains a tetracycline-responsive transcrip-
tional activator (tTA) driven by the CaMKIIa promoter.
The tTA ensures doxycycline-dependent expression, with
a 13-fold higher hTau protein expression than the
endogenous mouse tau protein levels in the absence of
doxycycline (Santacruz et al. 2005; Ramsden et al. 2005).
Mice in this study were not administered doxycycline.
The CaMKIIa promoter drives expression of the P301L-
hTau transgene primarily in forebrain (including hip-
pocampal and cortical) neurons. The F1 progeny of the
two transgenic parental strains (rTg4510) carries respon-
der and activator transgenes, necessary for the expression
of the tau transgene. Mice expressing the tTA activator
transgenes were maintained on 129S6 background strain
(Taconic) and mutant tau responder mice were main-
tained in the FVB/NCrl background strain (Taconic). The
wildtype, non-Tg littermates were of the FBV/129 back-
ground. Mice were screened by PCR using the following
primer pairs 50-GATTAACAGCGCATTAGAGCTG-30 and
50-GCATATGATCAATTCAAGGCCGATAAG-30 for the
tTA activator transgene and 50-TGAACCAGGATGGCT-
GAGCC-30 and 50-TTGTCATCGCTTC CAGTCCCCG-30
for the mutant tau responder transgene. rTg4510 and
non-Tg littermate F1 mice were bred at Taconic, Den-
mark. The mice were group-housed (5 animals/cage) and
received water and food ad libitum (Brogaarden, Den-
mark) as well as environmental enrichment. The light/
dark cycle was 12 h; room temperature was 21  2°C
and a relative humidity of 55  5%. Following termina-
tion by cervical dislocation, the mesenteric vascular bed
and brain were excised and placed in cold physiological
salt solution (PSS; composition in mM: NaCl 121; KCl
2.82; KH2PO4 1.18; MgSO4.7H2O 1.17; NaHCO3 25;
CaCl2 1.6; EDTA 0.03; glucose 5.5) saturated with carbo-
gen (O2 95%; CO2 5%) at pH 7.4. This study was
approved by the National Ethics Committee, Denmark,
and performed in accordance with Directive 2010/63/EU
on the Protection of Animals Used for Scientific Purposes
(European Commission, 2010).
Myography
Segments (1–2 mm length) of third-order mesenteric
arteries and middle cerebral arteries were isolated from
the WT and rTg4510 mice, mounted on 25 lm steel
wires and placed under isometric tension in chambers of
a wire myograph system (model 620M; Danish Myo
Tehcnology (DMT), Aarhus, Denmark) containing PSS
maintained at 37°C and saturated with O2 95%; CO2 5%.
Each artery segment was normalized by a passive stretch-
tension protocol, as previously described (Mulvany and
Halpern 1977). WT arteries had a mean diameter of
160.7  12.96 lm compared to 141  8.30 lm in
rTg4510 mice (n = 9; P = 0.2174 according to an
unpaired Students t test). In all arteries, the endothelium
was removed, which was tested by application of acetyl-
choline (data not shown). Cerebral arteries were
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constricted with either the a1-adrenoceptor agonist,
methoxamine (10 lmol/L), or the thromboxane A2 ago-
nist, U46619 (0.1 lmol/L); and the mesenteric arteries
were constricted with methoxamine (10 lmol/L). Once a
stable contraction had been generated, the Kv7.2-7.5
channel activator, S-1, was applied at 3 and 10 lmol/L.
Changes in force (mN) were recorded with a Powerlab 8/
25-LabChart 7 Pro data acquisition system (AD Instru-
ments Ltd., Oxford, United Kingdom).
Quantitative polymerase chain reaction
(qPCR)
qPCR analysis of KCNQ1-5, KCNE3-5, and KCNB1 in
the cerebral arteries, mesenteric arteries, and the neuronal
tissue of the inferior frontotemporal region surrounding
the middle cerebral artery of WT and Tg4510 mice was
performed as described previously in Jepps et al. (2014).
Briefly, RNA was extracted using the RNeasy Micro
Extraction Kit (Qiagen) and reverse transcribed using
Precision nanoScript2 Reverse Transcription Kit (Prime-
rdesign Ltd. Southampton, U.K.). Duplicate reactions
were performed in 20 lL volumes containing 10 lL Pre-
cision-iC SYBR green master mix (PrimerDesign Ltd.),
10 ng cDNA, 300 nmol/L primer (PrimerDesign Ltd.)
and made up to 20 lL with nuclease-free water. The
following cycling conditions were used in the CFX96
Real-Time PCR Detection System (Bio-Rad, Denmark):
initial activation at 95°C for 10 min, followed by 40
cycles of 95°C for 15 sec, and 60°C for 1 min, and data
were collected during each cycling phase. Melt curve anal-
ysis was performed to ensure each primer set amplified a
single, specific product. RT- samples and no-template
controls (NTCs) were run to assess contamination. Quan-
tification cycle (Cq) values were determined using Bio-
Rad CFX96 Manager 3.0 software and the single threshold
mode. The expression levels of the genes of interest are
expressed relative to the mean expression levels of the ref-
erence genes (Livak and Schmittgen 2001).
The mouse geNorm reference gene selection kit
(Primerdesign Ltd.) was used to identify the most stable
reference genes and to determine optimal number of refer-
ence genes required for reliable normalization of the genes
of interest in our samples (Vandesompele et al. 2002).
The reference genes used for cerebral and mesenteric
arteries were b-actin and cytochrome C1. For the brain,
the most stable reference genes were b-actin and Tyrosine
3-Monooxygenase/Tryptophan 5-Monooxygenase Activa-
tion Protein Zeta (YWHAZ). All primers (Table 1) were
designed and optimized by Primerdesign Ltd. The
sequences for the reference genes are commercially sensi-
tive and therefore unavailable from Primerdesign Ltd.
Table 1. Primers used in this study, designed and optimized by Primerdesign Ltd.
Gene Accession number Product length Sequence
Kcnq1 NM_008434 75 50-CTCGGAGTCACACGCTTCT-30
30-GCTTGAACTTCTTCTTCTTTACCAT-50
Kcnq2 NM_010611 111 50-CCCTCATTGGTGTCTCGTTCT-30
30-GGTTCCGCCGTTTCTCAAAG-50
Kcnq3 NM_152923 93 50-GAAGAGGGGCAGAGGAGGA-30
30-CCTGTACTTGGCGTTGTTCC-50
Kcnq4 NM_001081142 112 50-GTGGTCTTTGGCTTGGAGTATAT-30
30-CGATGACACAGAAGGGTTTCC-50
Kcnq5 NM_001160139 107 50-GTCAGATAAGAAGAGCCGAGAGA-30
30-CGATGGACTGGACCTGTTTCT-50
Kcne1 NM_008424 111 50-GTTTCCCCAAATCTCTCCACATT-30
30-AGCACACACTTCCCATTTCAAA-50
Kcne2 NM_134110 97 50-CCTGGTATTTAACTGAGTTGGACAT-30
30-GCACTGGGGGCTCTTGAAT-50
Kcne3 NM_001190869 99 50-CTCAACCATATCAAGCCACAGT-30
30-GCCTATCAGTCCCTCTTCTCT-50
Kcne4 NM_021342 88 50-GGAGGAGGGGGCTGATGA-30
30-CTGGTGGATGTTCTCGGAAGA-50
Kcne5 NM_021487 146 50-GCACGAAGAGACCTCAGACAT-30
30-GGACAGGAAAACAAGAACACCAT-50
Kcnb1 NM_008420 77 50-CCAGTCTCAACCCATCCTCAA-30
30-TGCTGCCCATCTCCAGTTC-50
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HEK cell electrophysiology
Monoclonal HEK293 cells stably expressing human Kv7.4
(Søgaard et al. 2001) were grown in Dulbecco’s modified
Eagle’s medium (Substrate Department, Panum Institute,
Copenhagen, Denmark), supplemented with 10% fetal
bovine serum (Th Geyer, Denmark), Glutamax (Substrate
Department, Panum Institute, Copenhagen, Denmark),
1% penicillin streptomycin (Sigma) and incubated at
37°C in 5% CO2. Cells were transfected with human
KCNE5 using siLentFectTM Lipid (Bio-Rad, Copenhagen,
Denmark), according to manufacturer’s instructions. K+
currents were recorded from these cells using an Axo-
patch 700B patch clamp amplifier (Molecular Devices,
Sunnydale, CA) generated and digitized using a Digidata
1322A hosted by a PC running pClamp 10.4 software
(Molecular Devices, Sunnydale, CA). Membrane current
recordings were made using b-escin (50 lmol/L, Sigma,
MO) perforated-patch technique in voltage-clamp mode.
Fire-polished patch pipettes had a resistance of 3–6 MO
when filled with a pipette solution of (mM): K+ Gluconate
(110), KCl (30), MgCl2 (0.5) HEPES (5), and EGTA (0.1),
pH 7.3. The external solution contained (mM): NaCl
(145), KCl (4), MgCl2 (1), CaCl2 (2), Hepes (10), and
glucose (10), pH 7.4. Control I/V’s were determined from
a holding potential of 80 mV using a step protocol with
+10 mV steps to a maximum potential of 50 mV, with
750 msec duration, returning to 30 mV to measure the
tail current. For each test potential the maximum current
amplitude was taken.
Results
Myography
In WT mouse middle cerebral arteries, the Kv7.2-7.5
activator, S-1 (3 and 10 lmol/L), produced concentra-
tion-dependent relaxations in the presence of both
methoxamine and U46619 (n = 4; Fig. 1A). The effect of
S-1 was attenuated in middle cerebral arteries from
rTg4510 mice at 3 and 10 lmol/L in the presence of
methoxamine and at 10 lmol/L in the presence of
U46619 (n = 4; Fig. 1A). Both WT and rTg4510 middle
cerebral arteries relaxed 100  0% to 1 lmol/L nicardip-
ine, the voltage-gated Ca2+ channel blocker (data not
shown; n = 3 for each). To determine whether Kv7 chan-
nel dysfunction in the rTg4510 mice occurred in other
arteries, we performed isometric tension measurements
Figure 1. Responses to the Kv7 channel activator, S-1, are impaired in cerebral arteries of Tg4510 mice compared to WT mice. Representative
traces of (Ai) WT and (Aii) rTg4510 mouse cerebral arteries contracted with U46619 before application of S-1. Mean data showing the
relaxations of the cerebral arteries to S-1 after preconstriction with either (Aiii) methoxamine or (Aiv) U46619 (n = 4). (B) (Bi and Bii)
Representative traces of the same experiments performed on the mesenteric arteries of WT and rTg4510 mice preconstricted with
methoxamine, followed by (Biii) the mean data (n = 6). The vasorelaxations to S-1 were the same in mesenteric arteries from WT and Tg4510
mice. *, ** and *** denote significance of P < 0.05, P < 0.01, and P < 0.001, respectively, according to an unpaired t test with Welch’s
correction.
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on mesenteric arteries from the same mice. In contrast to
the cerebral arteries, S-1 was equally effective at relaxing
mesenteric artery segments from WT and rTg4510 mice
(n = 6; Fig. 1B).
qPCR
We investigated whether the KCNQ or KCNE mRNA
expression was different in the middle cerebral arteries
between WT and rTg4510 mice. Expression of the most
common vascular KCNQ isoforms, namely KCNE1,
KCNQ4 and KCNQ5, were not different between in the
middle cerebral arteries in WT and rTg4510 (N = 3, with
each sample containing middle cerebral arteries pooled
from three animals; Fig. 2A). The expression of ancillary
subunits KCNE3 and KCNE4 were the same in middle
cerebral arteries from WT and rTg4510 mice (Fig. 2A).
KCNE5 expression predominated in the middle cerebral
arteries of WT mice, which was downregulated in
rTg4510 mice (Fig. 2A). We also investigated expression
of KCNB1 but there was no difference in the cerebral
arteries between WT and rTg4510 mice (Fig. 2A). In
mesenteric arteries, KCNE3 expression predominated in
both WT and rTg4510 mice; however, in contrast to the
middle cerebral artery, none of the genes investigated
showed any differences in expression between WT and
rTg4510 mice (N = 3, with each sample containing
mesenteric arteries pooled from three animals).
We also investigated the expression of all KCNQ iso-
forms, KCNE3-5 and KCNB1 in the neuronal tissue of the
inferior frontotemporal region surrounding the middle
cerebral artery of WT and rTg4510 mice. In this area of the
brain, the expression of KCNQ3 and KCNQ5 was down-
regulated in rTg4510 mice, with the other KCNQ genes
unaffected (n = 3; Fig. 3). There was no difference in
expression of KCNE3 and KCNE4 between WT and
rTg4510 mice, but KCNE5 was upregulated in the rTg4510
brain (n = 3; Fig. 3). KCNB1 was downregulated in the
brains of rTg4510 mice compared to WT (n = 3; Fig. 3).
Electrophysiology
We investigated the effect of overexpressed KCNE5 on
the Kv7.4 current in HEK cells (Fig. 4; n = 4–5). KCNE5
increased the amplitude of the Kv7.4 current at potentials
ranging from 0 mV to +50 mV, without affecting the
voltage-dependence of activation (Fig. 4). KCNE5 also
increased the Kv7.4 time for deactivation (Fig. 4). The
Figure 2. qPCR analysis of specific KCNQ and KCNE isoforms in cerebral arteries and mesenteric arteries of WT and Tg4510 mice (n = 3 for
each point). Differences in individual gene expression between WT and Tg4510 mice were compared using a one-way ANOVA followed by a
Bonferroni multiple comparisons test (* and *** denote significance of P < 0.05 and P < 0.001, respectively).
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activation kinetics of Kv7.4 were not significantly different
in the presence of KCNE5 (data not shown).
Discussion
Although it is known that cerebrovascular remodeling
occurs early in the onset of tauopathies, the precise mech-
anisms affecting cerebral artery tone in tauopathies
remain unknown. As such, the aim of this study was to
characterize the function and expression of the Kv7 chan-
nels in the cerebral arteries of a tauopathy-associated
dementia mouse model, namely rTg4510, compared to
age-matched control mice. This study is the first to iden-
tify a cerebral artery-specific impairment of Kv7 channel
function in a tauopathy-associated dementia mouse
model and we suggest this functional attenuation might
be due to a downregulation of the ancillary subunit,
KCNE5 in the cerebral arteries of the rTg4510 mice. This
is one of the first studies to investigate specific ion chan-
nel changes regulating cerebral artery contractility in an
animal model of neurodegenerative disease associated
with tau hyperphosphorylation.
The Kv7 channels are voltage-gated potassium channels
encoded for by the KCNQ genes (Robbins 2001). There
are five isoforms in the Kv7 channel family (Kv7.1-
Kv7.5), and Kv7.4 and Kv7.5 have been shown previously
to contribute to the regulation of myogenic tone in rat
cerebral and basilar arteries (Zhong et al. 2010a; Mani
et al. 2011). Activation of Kv7 channels in pressurized
cerebral arteries inhibited myogenic constriction at
>20 mmHg, whereas inhibition of the channels enhanced
the myogenic response at 20 mmHg (Zhong et al. 2010a).
However, there are no studies on the function of Kv7
channels in cerebral arteries from animal models of
dementia. Using the Kv7.2-7.5 activator S-1 (Bentzen
et al. 2006), this study found that Kv7 channel function
was attenuated in cerebral arteries of the rTg4510 mice.
In order to determine whether the Kv7 channel dysfunc-
tion occurred throughout the vasculature, we performed
isometric tension measurements on mesenteric arteries
from the same mice. In these experiments, S-1 was
equally effective at relaxing mesenteric artery segments
from WT and rTg4510 mice. These data suggest that Kv7
channel dysfunction is specific to the cerebral arteries of
rTg4510 mice and might contribute to the vascular dys-
function in tauopathies. A functional impairment of Kv7
channels in cerebral arteries is likely to result in increased
arterial tone and hypoperfusion of the neuronal tissue,
which is characteristic of the vascular dysfunction associ-
ated with tauopathies.
Rather than identifying a downregulation in the mRNA
encoding for the Kv7 channel a-subunits, particularly
KCNQ4 and KCNQ5, we found the ancillary subunit,
KCNE5, was downregulated in the rTg4510 mice. KCNE
genes encode for single transmembrane-spanning ancillary
subunits, which do not form function channels by
themselves, but can regulate the expression, biophysical
properties, and pharmacology of certain K+ channel
a-subunits, particularly the Kv7 channels (McCrossan and
Abbott 2004; Kanda and Abbott 2012; Jepps 2017). Previ-
ously, KCNE4 and KCNE5 were shown to predominate in
rat cerebral arteries, whereas KCNE3 and KCNE4 pre-
dominated in rat mesenteric arteries (Jepps et al. 2015;
Abbott and Jepps 2016). Thus, given the limited amount
of cDNA from the middle cerebral arteries, we focused on
these 3 KCNE isoforms and found only KCNE5 to be
downregulated. By comparison, in the mesenteric arteries
Figure 3. qPCR analysis of specific KCNQ and KCNE isoforms in
the brains of WT and Tg4510 mice (n = 3 for each point).
Differences in individual gene expression between WT and Tg4510
mice were compared using compared using a one-way ANOVA
followed by a Bonferroni multiple comparisons test (* and ***
denote P < 0.05 and P < 0.001, respectively).
2018 | Vol. 6 | Iss. 23 | e13920
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none of the genes investigated showed any differences in
expression between WT and rTg4510 mice. Additionally,
KCNE5 expression is known to reduce the current density
of KCNB1 (which encodes Kv2.1 channels) (David et al.
2015), which plays an important role in cerebral artery
reactivity (Zhong et al. 2010b), therefore we also investi-
gated expression of KCNB1 but it was not different in the
cerebral arteries between WT and rTg4510 mice.
To obtain some insight into whether a downregulation
of KCNE5 in middle cerebral arteries from rTg4510 mice
could underlie the impaired Kv7 function in these arter-
ies, we investigated the effect of KCNE5 on the Kv7.4 cur-
rent. We found Kv7.4 current amplitude and deactivation
times were increased in the presence of KCNE5. These
data are consistent with the idea that a downregulation of
KCNE5 would reduce Kv7 channel function - particularly
Kv7.4 channels that are known to be important (Zhong
et al. 2010a) - in the cerebral arteries of the tau trans-
genic mouse.
We also investigated the expression of all KCNQ iso-
forms, KCNE3-5 and KCNB1 in the neuronal tissue of
the inferior frontotemporal region surrounding the mid-
dle cerebral artery of WT and rTg4510 mice. These exper-
iments had two purposes: (1) to investigate if rTg4510
mice have changes in the mRNA expression of these
genes, many of which are known to be important in regu-
lating neuronal excitability; and (2) to ensure the expres-
sion profiles detected in the middle cerebral arteries were
not due to contamination from neurons. In the brain,
expression of KCNQ3 and KCNQ5 were downregulated
in rTg4510 mice, with the other KCNQ genes unaffected.
KCNQ3 and KCNQ5 encode for Kv7.3 and Kv7.5 chan-
nels, respectively, which underlie the slowly activating,
non-inactivating M-current in neurons (Lerche et al.
2000; Shah et al. 2002; Schroeder et al. 2000). Mutations
affecting the M-current are associated with the human
epileptic syndrome, benign familial neonatal convulsions
(BFNCs) (Cooper and Jan 2003); however this is the first
study to show a downregulation of these genes in a
tauopathy model. The implications of this finding should
be addressed in future studies investigating the impact of
NFTs on neuronal function. Additionally, the qPCR anal-
ysis found, in contrast to the cerebral arteries, KCNE5
was upregulated in this region of the rTg4510 brain. As
mentioned previously, KCNE5 can reduce the current
density of KCNB1 (David et al. 2015). Analysis of KCNB1
found that it was downregulated in the brains of rTg4510
mice compared to WT. These data suggest that if KCNE5
subunits were to constitute an interaction partner of
Kv2.1 channels in neurons, the upregulation of KCNE5
Figure 4. (A) Kv7.4 currents from HEK cells with (n = 4) and without (n = 5) KCNE5 co-expressed. (Bi) KCNE5 increased the Kv7.4 current
amplitude, (Bii) had no effect on the voltage-dependence of activation and (Biii) increased deactivation time. *, ** and *** denote significance
of P < 0.05, P < 0.01 and P < 0.001, respectively, according to a two-way ANOVA followed by a Bonferroni post-test.
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observed in this study might negatively regulate Kv2.1
channel expression leading to a reduced current density.
Future studies should investigate the implications of
Kv2.1-KCNE5 and this mechanism in neurodegenerative
diseases associated with NFTs.
We are aware that this study represents a preliminary
investigation of Kv7 channel function in cerebral arteries
of a tauopathy mouse model, as such there are multiple
limitations regarding these findings. First, the wire myog-
raphy data does not give an indication of how the myo-
genic response is affected in the cerebral arteries of the
rTg4510 mice. It will be important for future studies to
perform pressure myography experiments to elucidate
how the myogenic response is altered in relation to
impaired Kv7 channel function. Second, since the mice
were 11 months old, we are unable to determine whether
the functional impairment of Kv7 channel responses is a
contributory cause or consequence of the hyperphospho-
rylated tau. It is possible that hyperphosphorylated tau
has a direct effect in the cerebral arteries leading to an
important contributory cause of the reduced blood flow
associated with tauopathies. Future experiments should
investigate younger rTg4510 mice to determine when Kv7
channel function becomes impaired relative to the occur-
rence of NFTs. Third, we were unable to show any direct
interaction of KCNE5 and Kv7.4 due to a lack of available
tissue and poor KCNE5 antibodies. It is not known if
KCNE5 binds to Kv7.4 in cerebral artery myocytes, there-
fore we do not know if the Kv7 channel impairment is a
direct result of KCNE5 downregulation. We hope to be
able to resolve this in future studies. Finally, this study
only investigated the function of Kv7 channels in these
arteries. We believe it is highly probable that other ion
channels are affected in the cerebral arteries of the
rTg4510 mice. Identifying a functional impairment of
Kv7 channels is a starting point that we hope will stimu-
late future investigations into other ion channels regulat-
ing cerebral blood flow in tauopathy models.
Taken together, these data indicate that Kv7 channel
function is impaired in cerebral arteries of tau transgenic
mice, which may be a contributing factor to the changes
in vascular smooth muscle behavior that are associated
with increased cerebral artery resistance and decreased
cerebral blood flow in tauopathies (Perry et al. 1998; Vidal
et al. 2000; Zhao et al. 2014; Bradley et al. 2002; Stopa
et al. 2008; Merlini et al. 2016; Qiu et al. 2016). This
study has identified a downregulation of the single trans-
membrane-spanning ancillary subunit encoded for by
KCNE5 in the cerebral arteries of tau transgenic mice,
which, given its functional effect on Kv7.4 channels, could
represent the mechanism underlying the functional attenu-
ation of Kv7 channels in the cerebral arteries, specifically.
It is still unknown whether KCNE5 interacts with Kv7.4 in
native smooth muscle cells of the cerebral artery, thus it is
also possible that other mechanisms are responsible for
the impaired Kv7 channel function in the cerebral arteries
of the rTg4510 mice. Nonetheless, impaired Kv7 channel
function is likely to lead to increased cerebral artery tone,
particularly in the medium-sized cerebral arteries, thereby
increasing pulsations experienced by the smaller, thinner
arterioles and capillaries, which increases microvascular
damage contributing to the AD-related microvascular
pathology. It is important to note that the vascular pathol-
ogy associated with AD is multi-factorial involving degra-
dation of elastin and loss of a-smooth muscle actin
(Merlini et al. 2016). Many of these structural abnormali-
ties have been investigated previously; however this study
makes important advances into our understanding of how
smooth muscle behavior and contractility is affected in
AD-related vascular pathology contributing to the neu-
rone-hostile environment. Future investigations into such
mechanisms may offer improved therapeutic strategies to
protect against or retard tauopathies.
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